Related Experiment Video
Updated: Jun 4, 2026
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Nanomaterials for cancer therapy and imaging
Ki Hyun Bae1, Hyun Jung Chung, Tae Gwan Park
1Department of Biological Sciences and Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Korea.
Molecules and Cells
|March 2, 2011
Summary
Biomedical nanomaterials offer unique passive tumor targeting for cancer therapy and diagnostics. Advanced nanomedicine platforms enable targeted delivery of anti-cancer agents and imaging, paving the way for versatile theranostic nanosystems.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Nanomaterials (< several hundred nanometers) show promise for cancer therapy and diagnostics.
- Passive tumor targeting is a key characteristic of these nanomaterials.
- Nanomedicine platforms like liposomes and nanoparticles are explored for targeted anti-cancer agent delivery.
Purpose of the Study:
- To review the current state of biomedical nanomaterials for cancer therapy and imaging.
- To highlight the potential of nanomedicine platforms in oncology.
- To discuss the development of theranostic nanosystems.
Main Methods:
- Exploration of various nanomedicine platforms (polymeric micelles, liposomes, dendrimers, nanoparticles).
- Investigation of nanoscale delivery vehicles for small interfering RNA (siRNA).
- Design of multi-functional surface modifications for nanomaterials.
Main Results:
- Nanomaterials accumulate in tumor sites via leaky vasculature for selective payload delivery.
- Nanoscale siRNA delivery vehicles offer effective cancer therapeutic approaches.
- Surface modification enables versatile theranostic nanosystems for simultaneous therapy and diagnosis.
Conclusions:
- Biomedical nanomaterials are crucial for advancing cancer treatment and diagnosis.
- Nanomedicine platforms provide targeted delivery and enhanced therapeutic efficacy.
- Theranostic nanosystems represent a future direction for integrated cancer care.
